Welcome To Welox Pharma WHO-GMP | ISO 9001:2015

+91 7984303039 inquiry@weloxpharma.com
Translated into: English Spanish Portuguese French
+91 7984303039 inquiry@weloxpharma.com

Category

Show more...

Myhep Lvir 250 mg Ledipasvir and Sofosbuvir Tablet

  • Product Name : Myhep Lvir 250 mg Ledipasvir and Sofosbuvir Tablet
  • Category : Antiviral
  • Manufacturer Name : Mylan
  • Trade Name : Myhep Lvir
  • Available Dosage : 90mg+400mg
  • Packing : 28.0 tablets in 1 bottle
  • Pack Insert/Leaflet : Yes
  • Ingredients : Sofosbuvir , Ledipasvir
  • Formulation : Tablet
  • Therapeutic use : treatment of chronic hepatitis C virus (HCV) infection
  • Production Capacity : 100000

Introduction to Mylan Myhep Lvir 250 mg Tablet:

Mylan Myhep Lvir 250 mg Tablet is a prescription medication crucial for the treatment of chronic hepatitis C virus (HCV) infection. This combination therapy targets the virus to achieve viral clearance and restore liver function.


Uses of Mylan Myhep Lvir 250 mg Tablet:

Mylan Myhep Lvir 250 mg Tablet is used for:

  • Treatment of chronic hepatitis C virus (HCV) infection


Benefits of Mylan Myhep Lvir 250 mg Tablet:

  • Effective eradication of HCV virus from the body
  • Improvement in liver function and health
  • Prevention of liver cirrhosis and other complications associated with chronic HCV infection


Mechanism of Action of Mylan Myhep Lvir 250 mg Tablet:

  • Ledipasvir: Inhibits the NS5A protein needed for viral replication.
  • Sofosbuvir: Inhibits the NS5B polymerase enzyme required for viral RNA replication.